• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PERFUSION SYSTEMS FUSION HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BB811
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem Thrombus (2101)
Event Date 05/19/2016
Event Type  Injury  
Manufacturer Narrative
Upon receipt at medtronic's quality laboratory, visual inspection showed evidence of clotting within the device.Performance testing was performed.During the pressure integrity test the blood side pressure drop was comparable to historical averages.
 
Event Description
Medtronic received information that approximately 30 minutes into extracorporeal circulation, the customer noted a change in flow (flow volume was 4.3 liters and a pressure drop of approximately 100 mmhg) and thrombus formation within this fusion oxygenator.Thrombus formation was not observed in any other portion of the circuit.The customer elected to replace the device with another manufacturer's product.After the device was replaced, the customer observed thrombus formation near the left common carotid artery (cca), and a thrombectomy was performed.Suction was administered near the site and a large thrombus was visible inside of the cell saver; thrombus was also observed at the aortic arch, but does not appear to have been removed.The customer indicated it is unknown whether the thrombus originated in the oxygenator or the patient.A magnetic resonance imaging (mri) of the head was performed and did not show significant cerebral infarction.
 
Manufacturer Narrative
Upon completion of the investigation, results suggested the anticoagulation was likely inadequate and the high pressure experience was patient or clinically related.Performance testing for high pressure drop was conducted and the results indicated the device functioned as intended.The examination of the oxygenator showed the fiber bundle was stained, suggesting some type of protein build up, cryoprecipitate or cryofibrinogen that caused the initial flow restriction and the development of the thrombus.Medtronic will continue to monitor for similar occurrences and trends.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FUSION HOLLOW FIBER OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MEDTRONIC PERFUSION SYSTEMS
7611 northland drive
brooklyn park MN 55428
Manufacturer (Section G)
MEDTRONIC PERFUSION SYSTEMS
7611 northland drive
brooklyn park MN 55428
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5727893
MDR Text Key47487768
Report Number2184009-2016-00014
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K142784
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/23/2017
Device Model NumberBB811
Device Catalogue NumberBB811
Device Lot Number13143820
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/24/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/19/2016
Initial Date FDA Received06/15/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/16/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-